• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞病毒性视网膜炎患者的管理策略。

Management strategies for patients with cytomegalovirus retinitis.

作者信息

Hardy W D

机构信息

Pacific Oaks Medical Group Research Department and University of California, School of Medicine, Los Angeles 90211, USA.

出版信息

J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14 Suppl 1:S7-12. doi: 10.1097/00042560-199700001-00003.

DOI:10.1097/00042560-199700001-00003
PMID:9058612
Abstract

Each of the available antiviral agents has significant advantages and disadvantages, and the choice of therapy must include consideration of the extent and location of the eye disease, the patient's lifestyle and medical history, and the potential for drug interactions with the many other medications that a patient with advanced AIDS may be receiving. Treatment of CMV retinitis requires the active participation of several dedicated health care providers: the primary care physician, the ophthalmologist, nurses, and social workers. All are integral parts of a clinical treatment team engaged in providing optimal therapy. Most important, it is critical for patients to be involved with their own health care. Patients should be taught to recognize early signs of decreased vision and should be involved in important decision-making steps for their own treatment.

摘要

每种可用的抗病毒药物都有显著的优缺点,治疗方案的选择必须考虑眼部疾病的范围和位置、患者的生活方式和病史,以及与晚期艾滋病患者可能正在服用的许多其他药物发生药物相互作用的可能性。巨细胞病毒性视网膜炎的治疗需要几位专业医护人员的积极参与:初级保健医生、眼科医生、护士和社会工作者。他们都是参与提供最佳治疗的临床治疗团队的重要组成部分。最重要的是,患者参与自身的医疗护理至关重要。应教会患者识别视力下降的早期迹象,并应让他们参与自身治疗的重要决策步骤。

相似文献

1
Management strategies for patients with cytomegalovirus retinitis.巨细胞病毒性视网膜炎患者的管理策略。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14 Suppl 1:S7-12. doi: 10.1097/00042560-199700001-00003.
2
New developments in the treatment of CMV retinitis.巨细胞病毒性视网膜炎治疗的新进展。
Ophthalmology. 1996 Jul;103(7):999-1000. doi: 10.1016/s0161-6420(96)30548-4.
3
Therapeutic options for resistant cytomegalovirus retinitis.耐药性巨细胞病毒性视网膜炎的治疗选择。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14 Suppl 1:S13-21. doi: 10.1097/00042560-199700001-00004.
4
New issues in the management of cytomegalovirus retinitis in AIDS patients.艾滋病患者巨细胞病毒性视网膜炎管理中的新问题。
Am J Health Syst Pharm. 1998 Feb 15;55(4):392-5. doi: 10.1093/ajhp/55.4.392.
5
Promising new treatments for cytomegalovirus retinitis.
JAMA. 1995 May 10;273(18):1457-9.
6
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者巨细胞病毒性视网膜炎的治疗。
N Engl J Med. 1997 Jul 10;337(2):105-14. doi: 10.1056/NEJM199707103370207.
7
CMV retinitis: a clinical management update.巨细胞病毒性视网膜炎:临床管理最新进展
AIDS Patient Care STDS. 1996 Apr;10(2):86-93. doi: 10.1089/apc.1996.10.86.
8
AIDS therapy. New hope against blindness.
Science. 1995 Apr 21;268(5209):368-9. doi: 10.1126/science.7716538.
9
Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.西多福韦:艾滋病患者巨细胞病毒性视网膜炎治疗应用综述
Drugs. 1999 Aug;58(2):325-45. doi: 10.2165/00003495-199958020-00015.
10
Management of CMV infections in HIV-infected patients.HIV感染患者巨细胞病毒感染的管理。
Adv Exp Med Biol. 1999;458:77-87. doi: 10.1007/978-1-4615-4743-3_8.

引用本文的文献

1
Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.西多福韦:艾滋病患者巨细胞病毒性视网膜炎治疗应用综述
Drugs. 1999 Aug;58(2):325-45. doi: 10.2165/00003495-199958020-00015.
2
Ganciclovir. A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS.更昔洛韦。对其作为静脉内或口服维持疗法用于治疗艾滋病患者巨细胞病毒性视网膜炎的药物经济学评价。
Pharmacoeconomics. 1997 Aug;12(2 Pt 1):209-28. doi: 10.2165/00019053-199712020-00010.